Click it and Unblock the Notifications
ITI Pharma and Healthcare Fund - Direct Plan
3 Year Absolute Returns
76.35% ↑
NAV (₹) on 18 Dec 2025
16.97
1 Day NAV Change
-0.16%
Risk Level
Very High Risk
Rating
-
ITI Pharma and Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by ITI Asset Management Limited. Launched on 18 Oct 2021, investors can start with a minimum SIP ... Read more
NAV History
Fund Details
Returns Calculator
Asset Allocation
AUM
₹ 230.85 Cr
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 73.59% |
| Hospitals & Medical Services | 20.25% |
| Agro Chemicals/Pesticides | 2.57% |
| IT Enabled Services | 1.29% |
| Industrial Gases | 1.07% |
| Chemicals - Others | 0.93% |
| Net Receivables/(Payables) | 0.30% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 15.18% | ₹ 33.53 | Pharmaceuticals |
| Divi's Laboratories Limited | 9.12% | ₹ 20.15 | Pharmaceuticals |
| Max Healthcare Institute Limited | 5.42% | ₹ 11.98 | Hospitals & Medical Services |
| Lupin Limited | 5.40% | ₹ 11.92 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 5.19% | ₹ 11.47 | Hospitals & Medical Services |
| Cohance Lifesciences Limited | 4.84% | ₹ 10.70 | Pharmaceuticals |
| Aurobindo Pharma Limited | 3.93% | ₹ 8.68 | Pharmaceuticals |
| Torrent Pharmaceuticals Limited | 3.91% | ₹ 8.64 | Pharmaceuticals |
| Aster DM Healthcare Limited | 3.15% | ₹ 6.96 | Hospitals & Medical Services |
| Mankind Pharma Limited | 3.04% | ₹ 6.72 | Pharmaceuticals |
| Alkem Laboratories Limited | 2.87% | ₹ 6.35 | Pharmaceuticals |
| Fortis Healthcare Limited | 2.43% | ₹ 5.36 | Hospitals & Medical Services |
| Abbott India Limited | 2.33% | ₹ 5.15 | Pharmaceuticals |
| Wockhardt Limited | 2.28% | ₹ 5.04 | Pharmaceuticals |
| Granules India Limited | 2.11% | ₹ 4.65 | Pharmaceuticals |
| Neuland Laboratories Limited | 1.98% | ₹ 4.37 | Pharmaceuticals |
| FDC Limited | 1.55% | ₹ 3.42 | Pharmaceuticals |
| Healthcare Global Enterprises Limited | 1.55% | ₹ 3.42 | Hospitals & Medical Services |
| Supriya Lifescience Limited | 1.48% | ₹ 3.27 | Pharmaceuticals |
| Sumitomo Chemical India Limited | 1.43% | ₹ 3.15 | Agro Chemicals/Pesticides |
| Sagility India Limited | 1.29% | ₹ 2.85 | IT Enabled Services |
| Rainbow Childrens Medicare Limited | 1.28% | ₹ 2.83 | Hospitals & Medical Services |
| JB Chemicals & Pharmaceuticals Limited | 1.23% | ₹ 2.72 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 1.23% | ₹ 2.71 | Hospitals & Medical Services |
| Shilpa Medicare Limited | 1.22% | ₹ 2.71 | Pharmaceuticals |
| Dr. Reddy's Laboratories Limited | 1.22% | ₹ 2.70 | Pharmaceuticals |
| Gland Pharma Limited | 1.18% | ₹ 2.61 | Pharmaceuticals |
| GlaxoSmithKline Pharmaceuticals Limited | 1.18% | ₹ 2.61 | Pharmaceuticals |
| UPL Limited | 1.14% | ₹ 2.51 | Agro Chemicals/Pesticides |
| Onesource Specialty Pharma Limited | 1.09% | ₹ 2.41 | Pharmaceuticals |
| Caplin Point Laboratories Limited | 1.08% | ₹ 2.38 | Pharmaceuticals |
| Linde India Limited | 1.07% | ₹ 2.35 | Industrial Gases |
| Orchid Pharma Limited | 1.03% | ₹ 2.28 | Pharmaceuticals |
| Sai Life Sciences Limited | 1.02% | ₹ 2.24 | Pharmaceuticals |
| Cipla Limited | 1.02% | ₹ 2.26 | Pharmaceuticals |
| Strides Pharma Science Limited | 1.01% | ₹ 2.23 | Pharmaceuticals |
| Laurus Labs Limited | 0.97% | ₹ 2.13 | Pharmaceuticals |
| SRF Limited | 0.93% | ₹ 2.05 | Chemicals - Others |
| TTK Healthcare Limited | 0.32% | ₹ 0.70 | Pharmaceuticals |
| Net Receivables / (Payables) | 0.30% | ₹ 0.65 | Others |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 4.07% | -7.25% | 16.47% | 20.82% |
| Category returns | 12.61% | 0.69% | 15.54% | 26.16% |
Fund Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. ... Read more
AMC Details
Top Funds from Equity - Sectoral/Thematic
Top Funds from ITI Asset Management Limited
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ITI Balanced Advantage Fund - Direct Plan
Hybrid
Direct
|
₹14.29 | -2.20% | 25.46% | 55.93% | ₹399 | 0.63% |
Moderately High
|
|
ITI Balanced Advantage Fund - Direct Plan
Hybrid
Direct
|
₹14.29 | -2.20% | 25.46% | 55.93% | ₹399 | 0.63% |
Moderately High
|
|
ITI Liquid Fund - Direct Plan
Liquid
Direct
|
₹1,001.23 | 0.02% | 0.02% | -0.01% | ₹54 | 0.09% |
Low to Moderate
|
|
ITI Banking & PSU Debt Fund - Direct Plan
Income
Direct
|
₹13.72 | 7.49% | 24.37% | 35.76% | ₹37 | 0.15% |
Low to Moderate
|
|
ITI Banking & PSU Debt Fund - Direct Plan
Income
Direct
|
₹13.72 | 7.49% | 24.37% | 35.76% | ₹37 | 0.15% |
Low to Moderate
|
|
ITI Banking & PSU Debt Fund - Direct Plan
Income
Direct
|
₹13.72 | 7.47% | 24.36% | 35.74% | ₹37 | 0.15% |
Low to Moderate
|
|
ITI Arbitrage Fund - Direct Plan
Arbitrage
Direct
|
₹13.93 | 7.17% | 24.09% | 32.10% | ₹50 | 0.21% |
Low
|
|
ITI Arbitrage Fund - Direct Plan
Arbitrage
Direct
|
₹13.93 | 7.17% | 24.09% | 32.10% | ₹50 | 0.21% |
Low
|
|
ITI Arbitrage Fund - Direct Plan
Arbitrage
Direct
|
₹13.93 | 7.17% | 24.09% | 32.10% | ₹50 | 0.21% |
Low
|
|
ITI Dynamic Bond Fund - Direct Plan
Income
Direct
|
₹13.22 | 5.11% | 23.50% | 0.00% | ₹116 | 0.15% |
Moderate
|
FAQs
What is the current NAV of ITI Pharma and Healthcare Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of ITI Pharma and Healthcare Fund - Direct Plan Growth is ₹16.97 as of 18 Dec 2025. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of ITI Pharma and Healthcare Fund - Direct Plan Growth?
The Assets Under Management (AUM) of ITI Pharma and Healthcare Fund - Direct Plan Growth is ₹230.85 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of ITI Pharma and Healthcare Fund - Direct Plan Growth?
ITI Pharma and Healthcare Fund - Direct Plan Growth has delivered returns of -7.25% (1 Year), 20.82% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of ITI Pharma and Healthcare Fund - Direct Plan Growth?
ITI Pharma and Healthcare Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for ITI Pharma and Healthcare Fund - Direct Plan Growth?
The minimum lumpsum investment required for ITI Pharma and Healthcare Fund - Direct Plan Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
Best Midcap Mutual Funds With Nearly 25% Returns In Three Years | Check Full List -
Mutual Funds Increasing Stake in These Stocks -
I Am 38 Yrs, How Much SIP Should I Make In Mutual Fund With A CAGR of 10-15% To Get Rs 5 Cr By 15 Yrs? -
Indian Investors Are Getting This Mutual Fund Strategy Wrong — Are You One of Them? -
Top 5 Gilt Mutual Funds to Consider Post-RBI Repo’s Rs 1 Lakh Crore OMO Purchase -
Five Small-Cap Funds Deliver Up To More Than 30% CAGR Returns In Three Years -
Should You Bet On Passive Or Active Mutual Funds - What Works For Indian Retail Now? -
Understanding Mutual Fund Performance Metrics: Alpha, Beta, and Sharpe Ratio Explained -
Understanding Mutual Fund Performance: Key Financial Ratios Every Investor Should Know
-
Stop Falling For Mutual Fund Ads! Top 5 Ratios That Expose A Mutual Fund’s Real Story
- SBI Mutual Fund
- ICICI Prudential Mutual Fund
- HDFC Mutual Fund
- Nippon India Mutual Fund
- Aditya Birla Sun Life Mutual Fund
- Kotak Mahindra Mutual Fund
- UTI Mutual Fund
- Axis Mutual Fund
- Tata Mutual Fund
- Bandhan Mutual Fund
- Mirae Asset Mutual Fund
- DSP Mutual Fund
- Edelweiss Mutual Fund
- HSBC Mutual Fund
- Invesco Mutual Fund
- Franklin Templeton Mutual Fund
- Motilal Oswal Mutual Fund
- PPFAS Mutual Fund
- Canara Robeco Mutual Fund
- Quant Mutual Fund
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Sign in with Google- Male
- Female
- Others
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+